PhoenixBio Co., Ltd. (TYO:6190)

Japan flag Japan · Delayed Price · Currency is JPY
500.00
+6.00 (1.21%)
Feb 17, 2026, 9:13 AM JST
Market Cap2.01B +51.3%
Revenue (ttm)1.60B +4.4%
Net Income-205.00M
EPS-50.78
Shares Out4.07M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume53,500
Average Volume30,695
Open496.00
Previous Close494.00
Day's Range493.00 - 503.00
52-Week Range252.00 - 809.00
Beta0.26
RSI47.61
Earnings DateFeb 13, 2026

About PhoenixBio

PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. The company was founded in 2002 and is headquartered in Higashihiroshima... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 69
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 6190
Full Company Profile

Financial Performance

Financial Statements